MBX Biosciences Inc (NAS:MBX)
$ 62.08 -1.57 (-2.47%) Market Cap: 2.95 Bil Enterprise Value: 2.51 Bil PE Ratio: 0 PB Ratio: 6.74 GF Score: 12/100

MBX Biosciences Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 07:00 PM GMT
Release Date Price: $28.94 (-0.24%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MBX.OQ - MBX Biosciences Inc
MBX Biosciences Inc at Barclays Global Healthcare Conference
Mar 11, 2026 / 07:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi everyone, good afternoon. Thanks so much for joining us here in Miami for the Barclays 28th annual Global Healthcare conference. Very happy to have MBX here with us today. I'm Ellie Merle, one of the biotech analysts here at Barclays. Joining us from MBX is Chief Executive Officer Kent Harlu, Chief Medical Officer SAM Mazzouli. Apologies if I butchered your name. Feel free to correct me.

Really? Okay, great.

Thank you both so much for the time. A lot of exciting things to talk about in your pipeline. But maybe first, I'll pass it to you to give an overview of your platform technology and clinical programs.

--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot